FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Sun Pharmaceutical Industries buPROPion Hydrochloride Extended Release Recall

buPROPion Hydrochloride Extended Release Tablets USP (SR) 150 mg Rx Only 60 tablets Dis…

Sun Pharmaceutical Industries, Inc. · Cranbury, NJ

Risk level
Class III
Reported by FDA
Jul 27, 2016
Recall ID
D-1446-2016
Check your lot numberHow we source this data

Summary

Sun Pharmaceutical Industries recalled buPROPion Hydrochloride Extended Release starting Jun 27, 2016. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1446-2016 on Jul 27, 2016. Reason: Failed Dissolution Specifications. Status: Terminated.

Why it was recalled

Failed Dissolution Specifications

Product description

buPROPion Hydrochloride Extended Release Tablets USP (SR) 150 mg Rx Only 60 tablets Distributed by Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol 389-350 Gujarat India ---- NDC 47335-737-86

Lot numbers, UPCs & expiration codes

Lot JKN3477A, exp 07/2016

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1446-2016
Classification
Class III
Status
Terminated
Recall initiated
Jun 27, 2016
FDA report date
Jul 27, 2016
Quantity
16,085 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Sun Pharmaceutical Industries, Inc.

Original FDA data

Every field from FDA enforcement report D-1446-2016, exactly as published.

Show all FDA fields
City
Cranbury
State
NJ
Status
Terminated
Country
United States
Event ID
74696
Address
270 Prospect Plains Rd
Code information
Lot JKN3477A, exp 07/2016
Postal code
08512-3605
Report date
Jul 27, 2016
Product type
Drugs
Recall number
D-1446-2016
Classification
Class III
Recalling firm
Sun Pharmaceutical Industries, Inc.
Product quantity
16,085 bottles
Termination date
Mar 27, 2018
Reason for recall
Failed Dissolution Specifications
Voluntary / mandated
Voluntary: Firm initiated
Product description
buPROPion Hydrochloride Extended Release Tablets USP (SR) 150 mg Rx Only 60 tablets Distributed by Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol 389-350 Gujarat India ---- NDC 47335-737-86
Distribution pattern
Nationwide
Recall initiation date
Jun 27, 2016
Initial firm notification
Letter
Center classification date
Jul 20, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1446-2016, published Jul 27, 2016. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls